Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Contraceptives
Duramed and Paladin sign SEASONALE product Canadian license and distribution agreement
November 24th, 2005
Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., and Paladin Labs, Inc., (PLB) have signed a license and distribution agreement granting Paladin an exclusive license to seek approval for and to market SEASONALE extended-cycle oral contraceptive in Canada. Paladin currently markets Duramed's Plan B emergency contraceptive in Canada. The terms of the agreement were not disclosed. On September 30, 2005, Paladin filed on behalf of Duramed the new drug submission for SEASONALE with the Therapeutic Products Directorate of Health Canada. Currently, SEASONALE is only approved and marketed in...
Source: Women's Health Weekly (2005-11-24)
|
